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In the United States, rates of foodborne illness caused by Salmonella have not 
changed significantly. One study in this thesis estimated Salmonella prevalence and 
antimicrobial resistance of various samples from conventional (n=181) and organic 
(n=252) farms. Rates of Salmonella contamination were significantly lower on 
conventional than organic farms. Antimicrobial resistance was significantly higher on 
isolates from conventional versus organic farms. These findings suggest that poultry 
production practices may have significant effects on prevalence and antibiotic 
resistance patterns of Salmonella. 
The other study assessed the efficacy of a Salmonella control strategy using anti-
Salmonella antibodies, two chicken cell lines, an HD-11 macrophage and a DF-1 
fibroblast line, and Salmonella serovars Typhimurium and Enteritidis. In DF-1 cells, 
treatment showed decrease adherence of the pathogen. However, in HD-11 cells, 
  
treatment showed an increase in pathogen adherence, indicating a more detailed 
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Chapter 1: Introduction 
Salmonella is a genus of Gram-negative bacteria that can persist in the 
gastrointestinal (GI) tract of humans and animals and causes the disease, called 
salmonellosis.  The Salmonella genus is comprised of only two species, S. enterica 
and S. bongori. The enterica species is further branched into six subspecies enterica, 
salamae, arizonae, diarizonae, houtenae, and indica, and altogether it has more than 
2,500 different serotypes.  It is estimated by the Center for Disease Control and 
Prevention (CDC) that there are 48 million cases of domestically acquired foodborne 
illness annually, of which nontyphoidal Salmonella contributes to 1.03 million cases. 
Moreover, foodborne nontyphoidal Salmonella is estimated to cause 19,336 cases of 
hospitalization and 378 deaths annually (1). The majority of human outbreaks of 
Salmonella reported to the CDC are attributed to either chicken or egg products (2). 
Economic estimates of human nontyphoidal Salmonella infection place the annual 
burden between $1.5 - $10.9 billion, when accounting for medical costs and 
productivity loss (3). Adoption of Salmonella control measures may be able to 
decrease incidence of salmonellosis associated with poultry and poultry products. 
Cost-effective control measures that will maximize benefit to the consumers, 
producers and poultry industry/farms must be studied further. 
 While serovar specific rates of salmonellosis have changed since 1996-1998, 
the overall incidence of laboratory-confirmed Salmonella cases has remained 
consistent through 2012 (4). During 1998-2008, of the 1,491 reported Salmonella 
outbreaks, 403 outbreaks were caused by a single serotype and a single-food 




and 16%, respectively (2). Moreover, from these 403 outbreaks, 36% were caused by 
Salmonella Enteritidis and 14% were caused by Salmonella Typhimurium. As a hardy 
pathogen, Salmonella is able to survive in many different environments and 
Salmonella contamination on farms may come from a variety of sources, including 
wild animals and rodents, insects, feed and humans on the farms themselves (12, 
67,119, 120, 121). While decontamination of poultry meat or eggs may help decrease 
human foodborne illness, in order to successfully decrease the incidence of poultry 
associated Salmonella infections, multiple intervention strategies are needed. 
 It is also important to address the growing organic market in the United States. 
The Organic Trade Association reported that the organic food industry has grown 
from $1.0 billion dollars in 1990 to $26.7 billion in 2010. Further, organic poultry 
meat captured $294 million of the total $470 million spent on organic meat in 2010 
and in 2008, total organic egg sales were valued at $154.8 million (5). Compared to 
their conventional counterparts, organic operators certified by the United States 
Department of Agriculture are not allowed to use growth promotants, drugs or 
synthetic antibiotics. Studies focusing on the incidence and antimicrobial resistance 
of Salmonella associated with chicken have shown mixed results (17, 20, 21, 25). 
Many of these studies have focused on contamination in broiler hens and their 
carcasses, leaving us with gaps in our knowledge specifically for laying hens. 
Moreover, due to the lack of antibiotic use available on these organic farms, the 
efficacy of alternative control strategies such as passive immunization, pro or pre-
biotics, bacteriophages, fermented feed or naturally occurring antimicrobial peptides 




information available for organic laying hens, these studies look to understand the 
epidemiology of Salmonella in organic chicken layer farms and efficacy of alternative 
Salmonella  
1.1 Goal and Objectives 
The goal of this study was to contribute to the growing body of knowledge associated 
with the epidemiology and control of Salmonella at the production level. The 
following objectives were set in this study: 
• Prevalence, distribution, and antimicrobial resistance of Salmonella serovars 
isolated from organic and conventional laying hen farms 
• Evaluate the efficacy of egg-yolk antibodies as a novel Salmonella in-feed 
additive control strategy using in vitro poultry cell models  
1.2 Salmonella Overview  
Salmonella represents a genus of Gram-negative, rod-shaped bacteria from the 
family Enterobacteriaceae. The pathogen is named after Daniel Salmon, an American 
veterinary pathologist, and can be found in a variety of different environmental 
sources. Human associated Salmonella infections, known as salmonellosis, are 
typically associated with the onset of gastroenteritis within 12 to 72 hours of 
infection. In mild disease, symptoms typically involve diarrhea and abdominal 
cramps, which may last 4-7 days.  More severe cases of Salmonella infection may 
spread from the intestine to the blood stream to cause systemic illness; typically 




To differentiate between Salmonella enterica at the subspecies level, a system 
was devised to characterize strains by serotyping based on the immunoreactivity 
against two surface structures, the O and H antigens. First, isolates are identified at 
the genus and species level by biochemical test. Next, a series of independent 
agglutination tests determine the O and H antigens on the surface; Salmonella are 
then placed into different serotypes based on a Kauffman-White scheme. In 2007, the 
CDC officially recognized over 2,500 different serovars of Salmonella, with 
approximately 60% belonging to subspecies enterica (122). However, only a 
relatively small subset of these serovars cause human illnesses, with the top 100 
serotypes accounting for 98% of all isolated recovered by the CDC (122).  
Salmonella is recognized as a causative agent of zoonotic and emerging 
infectious disease in the United States. Salmonella is often host-adapted, meaning 
certain serovars of the pathogens can cause disease only in particular species of 
animals. Humans can be infected from a variety of sources, however not all 
Salmonella serovars can cause illness in humans (2, 6). For example, S. Pullorum 
causes disease in chickens, while S. Enteritidis is able to colonize chicken without 
causing any symptomatic disease in adult chickens (9). Moreover, it has been 
demonstrated that Salmonella are able to survive in a variety of environments ranging 
in moisture content, pH, salinity and heat (124, 125). Since Salmonella contamination 
and persistence may occur in meats, vegetables, fruits and animals, human 
Salmonella infection remained relatively high and consistent for the past 15 years, 




1.3 Human Associated Salmonella 
In 2011, the CDC noted that the top five identified serovars of Salmonella enterica 
associated with humans were Enteritidis, Typhimurium, Newport, Javiana and I 
4,[5],12:i:-. (1). It has been reported that severity of salmonellosis is dependent on the 
serotype causing the illness. For example, a study focused on the outcomes of 
individuals infected with different serotypes of Salmonella, found that 24.2% of S. 
Typhimurium cases resulted in hospitalization, while S. Enteritidis cases resulted in 
hospitalization of 20.6%. In the same study, of the 2,830 individuals who were 
infected with S. Heidelberg, 13.5% of those led to invasive disease compared to 1.4% 
of S. Newport cases (7).   
 To better understand how the epidemiology of Salmonella infection has been 
changing, the Foodborne Disease Active Surveillance Network (FoodNet) compared 
the rates of the top, human associated laboratory-confirmed Salmonella serotypes in 
2012 to previous years through 1996. When compared with the 1996-1998 rates, 
serovars Enteritidis and Newport were both higher, while the relative rate of 
laboratory confirmed S. Typhimurium infections was lower. Unfortunately, the 
changes over time for serotypes Javiana and I 4,[5],12:i:- were not tracked.  
 Between 1998 and 2008, a total of 1,491 outbreaks of Salmonella were 
reported to the Foodborne Disease Outbreak Surveillance System (FDOSS). 
Outbreaks are only defined as the occurrence of two or more cases of illness resulting 
from ingestion of the same food (2). Of the reported outbreaks, 403 were attributable 
to a single serotype and single food commodity and a total of 47 different serotypes 




Newport and Heidelberg) caused more than 60% of the 403 outbreaks traceable to a 
single food commodity; S. Enteritidis caused 36% of the 403 outbreaks, while S. 
Typhimurium,  Newport and Heidelberg caused 14%, 10% and 6%, respectively. Of 
the 144 S. Enteritidis outbreaks, eggs and chicken were implicated in 65% and 13% 
of the outbreaks, respectively. Out of the 58 S. Typhimurium outbreaks, eggs and 
chicken were implicated in 7% and 26% of the cases, respectively (2).  
 Salmonellosis may also occur due to contact with contaminated animals or 
environments. It has been estimated that contact with animals has led to 120,000 
cases of Salmonella caused illness, leading to 2,400 hospitalizations and 47 deaths 
(8). Serovar specific rates of salmonellosis caused by contact have not been 
estimated, though several species have been implicated as important reservoirs for 
Salmonella illness through contact. Live poultry, dogs, cats, reptiles and rodents have 
all previously been implicated in multi-state outbreaks of Salmonella. It is important 
to better understand Salmonella persistence in these vectors and strategies for 
controlling infection from these sources. 
1.4 Salmonella Associated with Poultry  
Salmonella serovars associated with poultry have been dramatically changing 
since the early 1900’s. Previously, serovars S. Gallinarum and S. Pullorum were 
endemic to poultry flocks in the United States. These two host-adapted serovars cause 
severe illness in poultry; symptoms include anorexia, diarrhea, dehydration, 
decreased egg production and increased mortality. In 1935, the United States 
Department of Agriculture (USDA) established the National Poultry Improvement 




allowed S. Gallinarum and S. Pullorum to be eradicated from commercial poultry 
flocks by the 1970’s. It is believed that the disappearance of these pathogens left a 
niche for other pathogens to fill (9, 10). Another theory states that S. Enteritidis was 
associated primarily with rodents and the interaction between these two species 
allowed S. Enteritidis to transfer to poultry flocks (11). Others attribute the rise in S. 
Enteritidis in poultry to competitive exclusion by S. Gallinarum. It is thought that the 
presence of S. Gallinarum increased flock immunity against S. Enteritidis, ensuring 
colonization only by the host-adapted serovar (9).  
Transmission of Salmonella can occur either horizontally and vertically. 
Horizontal transmission typically occurs through fecal-oral transmission; however 
other experiments acknowledge that Salmonella may be transmitted among poultry 
flocks through environmental contamination (12). Vertical transmission occurs when 
infected ovarian tissues pass on the bacteria to the developing egg before oviposition. 
In that case, the Salmonella will contaminate and persist in the egg yolk and will be 
found in the newly hatched chick.  Should the new chick survive disease, they may 
act as a carrier to infect other hens (13).  
While S. Enteritidis briefly surpassed S. Typhimurium as the number one 
human associated serovar in the 1990’s, quality assurance programs put in place by 
NPIP and  egg producers may account for the decrease in prevalence of S. Enteritidis 
in eggs and poultry (9, 14). Regulations to control S. Enteritidis have been put into 
place as recently as 2009, with the FDA’s egg safety rule, which was meant to 
decrease infection in chickens and their associated eggs by the serovar  (76). It is 




Salmonella serovars, S. Kentucky and S. Heidelberg (15). The present study was 
aimed to contribute to the current knowledge of work by testing the prevalence, 
distribution and antimicrobial resistance of Salmonella isolated from laying hen farms 
here in the United States. By understanding these characteristics of Salmonella in 
these farming systems, targeted control strategies can be put in place to better address 
the Salmonella serotypes most often associated with poultry products. 
1.5 Antimicrobial Interventions in Poultry Practices 
A number of studies have been performed to understand the effect of farming 
system on the prevalence and distribution of antimicrobial susceptible and resistant 
Salmonella. Many of these studies focused on the effect of organic or conventional 
farming practices on broiler chickens; while Salmonella contamination is quite 
variable between farming systems, antimicrobial resistance was typically found to be 
higher in Salmonella isolates recovered from conventional compared to organic farms 
(16-20). 
 A gap of knowledge exists in our understanding of Salmonella prevalence on 
laying hen farms in the United States, while many studies have been performed in the 
European Union (20-22). In the E.U., antimicrobials are not allowed to be used as a 
method to control Salmonella in poultry with the exception of a very small set of 
specific cases, such as poultry presenting clinical salmonellosis causing “undue 
suffering to the animals” or salvaging valuable genetic material from “elite” or 
research flocks. In either of these cases, administration of antimicrobial must be done 
under the supervision of a competent authority figure (23).  However, in the United 




exposed to different classes of antimicrobials, depending on poultry type 
(conventional laying hens, broilers) (24). Organic farms are certified by the USDA 
are not allowed to sell any products as organic when they come from animals treated 
with antimicrobials and the use of vaccines as a treatment strategy is encouraged. 
Meanwhile, conventional farming practices are allowed to use a variety of 
antimicrobials. Conventional laying hen farms are limited to using bacitracin, tylosin 
and chlortetracycline, while broilers can use a wider variety of antimicrobial classes 
(24).  
1.6 Alternative Salmonella Poultry Control Strategies 
Antimicrobial resistance has been documented in broilers and layers in both 
organic and conventional laying hen systems (20, 21, 25). Further, concerns about the 
use of antimicrobials and growth hormones in live-stock have been driving consumer 
demand to the organic sector, where the use of antimicrobials is banned. A variety of 
alternative antimicrobial intervention strategies exist to address the issue of 
Salmonella in poultry, however continued work is needed to better understand the 
efficacy of these strategies. Further, it is believed that reducing Salmonella at the 
poultry-production chain may minimize contamination as poultry products move 
from the farm to the table. 
To help reduce Salmonella at the production level, a number of strategies are 
being developed. The majority of these strategies are meant to be added to the feed 
itself in order to reduce enteric colonization of Salmonella. The in-feed additives are 
devised to target the pathogen specifically or to modulate several factors of the 




One of these strategies is to acidify the environment of the gastrointestinal 
tract of the chicken, through the use of fatty-acids or fermented liquid feed. It is 
believed that the successful acidification of the gastrointestinal environment will 
affect the bacteria by either inhibiting their growth (bacteriostatic) or actively killing 
them (bactericidal) (29). Short-chain and medium-chain fatty acids have been 
demonstrated to have both bacteriostatic and bactericidal effects in vitro, though some 
of these tests suggest that exposure to fatty-acids may increase invasiveness and 
survival at low pH’s (30, 31). Studies with fermented liquid feed have generally been 
more positive. Fermentation of the liquid feed may occur via back slopping (adding a 
previously fermented batch as inocula) or through addition of fresh lactic acid 
bacteria; these two processes lead to the increase concentration of lactic acids 
produced by lactic acid bacteria, leading to low pH’s. Of the few trials testing the 
effects of fermented liquid feed, the general consensus showed the fermented liquid 
feed was able to significantly decrease Salmonella colonization when compared to 
their respective control groups (32, 33). More work is needed to better understand the 
best combination of treatments that will be able to significantly decrease Salmonella 
colonization in poultry. 
The application of pro-, pre-, or synbiotics to modulate the microbiota of 
poultry represents other alternatives to antimicrobials. Probiotics are live bacteria that 
are meant to improve the intestinal microbial balance, while prebiotics are ingredients 
added to the feed in order to stimulate the growth and/or activity of beneficial 
bacteria; synbiotics represent the combination of both probiotic strains of bacteria and 




poultry include Lactobacillus, Enterococcus, Pediococcus and Bifidobacteria and the 
application of these probiotics have been shown to decrease in Salmonella 
contamination in broiler chickens (34-36). It is believed that these bacteria may 
overcome Salmonella through increased competition for receptor sites, nutrients and 
other metabolites. Designing of the most effective synbiotic will require a deeper 
understanding of the metabolism of these probiotic bacteria and their mechanism of 
action against enteric pathogens.  
 Vaccination may also be an alternative to antimicrobial therapy, though 
development of an effective vaccine requires a comprehensive understanding of host 
and pathogen interaction. Vaccines have been designed using a variety of different 
antigens; both killed and live-attenuated Salmonella strains have been used for 
vaccination and have shown a protective effect (37). After vaccination occurs, a 
phagocytic cell engulfs the foreign body; fragments of the foreign body is presented 
by a helper T cell to B-lymphocytes, leading to the production of antigen specific 
antibodies by plasmocytes. Antigen specific antibodies may help induce phagocytosis 
of foreign pathogens or help lead to the lysis of the bacteria. A class of the antigen 
specific antibodies, known as immunoglobulin-Y (IgY) are deposited specifically into 
the egg-yolk of the chicken, to deliver passive immunity to the developing chick. This 
antibody can be found exclusively in the egg-yolk and is analogous to mammalian 
Immunoglobulin-G, though it has an extra fragment in the Fc region (38, 39). Due to 
the complex nature of an immune response and the pathogenicity of Salmonella, 
development of a vaccine effective across the multiple serotypes found in poultry will 




 Adhesins may prove to be an important target for vaccination. Adhesins 
represent a class of cell-surface components that are necessary for binding and 
colonization to a particular surface. Salmonella has a variety of adhesins, though it is 
not well understood which adhesins are required for adherence and colonization of 
poultry. Type 1 Fimbriae have been implicated in S. Enteritidis colonization of the 
oviduct tract in poultry, while flagellae were implicated in S. Enteritidis gut 
colonization (40, 41). For S. Typhimurium attachment to HeLa cells, a type 1 
fimbriae leads to reversible binding (42). Furthermore, plasmid encoding fimbriae 
(pef), thin aggregative fimbriae (tafi) and long polar fimbriae (lpf) have been 
implicated in S. Typhimurium biofilm formation on chicken intestinal epithelium 
(43). In addition to these, Salmonella have other fimbral adhesins and atypical 
structures, such as flagellum and type three secretion systems, which contribute to 
adhesion to other tissues (44). Information specifically targeting Salmonella adhesion 
to poultry tissues must be studied in more detail for better understanding of serovar 
specific adhesion factors. Vaccination against these antigens could be useful for 
producing antibodies specifically to prevent initial colonization. 
Like active immunization, passive immunization through oral-ingestion of 
anti-Salmonella antibodies may prove to be effective in decreasing Salmonella 
contamination in poultry (38, 45, 46). After immunization against adhesins, a hen will 
lay eggs with a high titer of specific antibodies that can be recovered from the yolk. 
After collection of these antibodies, they may be administered either in the feed or 
water provided to the hens, where they will preferentially bind to Salmonella 




tract of the chicken. Several studies have been performed using non-poultry cells 
lines and anti-Salmonella antibodies have showed positive results; however, the 
follow up in vivo studies have showed poor efficacy and attributed this response to 
the antibodies being denatured in the gastrointestinal tract of the chicken (47, 48).  
The failure of passive immunity effectiveness may be attributable to an improper in 
vitro model of infection or too low of a small concentration range tested or an 
improper delivery system used. There is a need for more research to be done in the 
area of passive immunization using IgY: the development of a proper vaccine target 
that will work against multiple Salmonella serotypes and finding a delivery system 
that will allow antibodies to remain intact are both necessary before this strategy is 
adopted widely. One of the aims of the present study was to add knowledge to this 
body of work by testing whether or not antibodies produced against multiple 








Chapter 2: Prevalence and Antibiotic Susceptibility of 
Salmonella serovars in organic and conventional laying hen 
farms 
2.1 Abstract  
Salmonella is a gram-negative pathogen, capable of causing foodborne-illness 
in humans. In the United States, of the 403 Salmonella outbreaks attributable to a 
single serovar and food commodity, 28% of these were traced back to chicken eggs 
(2). The majority of studies linking human Salmonella food-borne infection to 
chickens have focused on the environments and the carcasses of broiler laying hens. 
The growing demand for organic eggs market coupled with the inability of organic 
farmers to use antibiotics prophylactically, has made it important to study the 
prevalence of Salmonella contamination in conventional and organic laying hen 
farms. In this study, a total of 433 (181 conventional, 252 organic) samples were 
collected between April 2013 and January 2014, from a total of nine farms (three 
conventional, six organic) in order to estimate the contamination rates of Salmonella 
on these two farming systems. Samples were collected from the laying hen 
environments (bedding, dust baths), feed/water  and the eggs themselves. We aimed 
to identify the top egg associated Salmonella serovars, S. Enteritidis, S. Typhimurium 
and S. Heidleberg, as well as determine antimicrobial resistant phenotypes of the 
Salmonella isolates. Results showed that the rates of Salmonella contamination were 
significantly (p = 0.008) higher on organic farms (20.2%, 51/252) than they were on 
conventional farms (10.5%, 19/181) and S. Typhimurium was the most prevalent 
serovar on both farming systems. Of S. Typhimurium isolates recovered, the serovar 




organic farm isolates (43.1%, 22/51)).  Moreover, isolates resistant to a single or 
multiple antimicrobial agents were found in significantly (p = 0.026) higher rates in 
conventional farm isolates (84.2%) than they were in organic farm isolates (52.9%). 
These findings indicate that implementation of proper biosecurity measures in both 
farming systems is important to control Salmonella contamination and a novel 
approach alternative to use of antimicrobials is essential to deal with the growing 
resistance of Salmonella which is a major public health concern. 
2.2 Introduction 
Salmonella enterica represent the most common bacterial foodborne 
pathogen, infecting a wide range of animal hosts and typically causes gastroenteritis 
in humans. In 2012, the Foodborne Diseases Active Surveillance Network (FoodNet) 
of the Center for Disease Control and Prevention (CDC) identified 7,800 laboratory 
confirmed cases of salmonellosis associated with foodborne disease, causing 2,284 
hospitalizations and 33 deaths (51). Furthermore, the CDC estimates the rate of 
foodborne Salmonella infection to be approximately 16.42 cases per 100,000 people. 
While serovar specific rates of laboratory confirmed Salmonella infections have 
fluctuated, overall rates of laboratory confirmed infections with Salmonella have not 
changed significantly compared to average annual incidence since 1996-1998 (51). 
From 1998 to 2008, a total of 1,941 Salmonella outbreaks were reported to the 
Foodborne Disease Outbreak Surveillance System (FDOSS) and 34% of these were 
assigned to a single food commodity. Eggs and chicken meat were the most 
commonly identified food commodities, accounting for 112 and 64 outbreaks, 




Salmonella enterica serovars Enteritidis, Heidelberg and Typhimurium, accounting 
for 83%, 9% and 4%, respectively (2). From 2009 to 2010, the CDC found that eggs 
and poultry were associated with 2,231 and 826 outbreaks, respectively (51). 
The United States Department of Agriculture (USDA) revealed that USDA 
certified organic food growers in the US sold more than $3.5 billion worth of organic 
commodities in 2011 and estimated that organic chicken eggs and broiler chicken 
sales accounted for $276 million and $115 million, respectively (52). Available 
information indicated that average annual growth of organic egg sales between 2005 
and 2007 was 19% (53). Surveys indicate organic foods are perceived to be safer and 
healthier than their conventional counterparts and these attitudes have created higher 
demand for these products (54-56). To address the increasing consumer demand, 
acreage of certified organic farmland has been increasing and the Economic Research 
Service has estimated that organic acreage has increased from 1.3 million acres in 
1997 to 4.8 million acres in 2008. Identifying the prevalence, diversity and resistance 
patterns of Salmonella in poultry can contribute to better our understanding of 
biosecurity measures in these farming systems.  
USDA certified organically raised live stock must use 100% organic feed, 
provide animal access to outdoors and must withhold the use of antibiotics and 
growth hormones.  These organic standards required by the USDA only address 
production and processing procedures and does not guarantee nutritional quality or 
safety of the products (60). On the other hand, in conventional laying hens, 




therapeutic agents in feed or drinking water. In addition, tylosin is also approved as a 
growth promoting agent (24).  
Currently, there are numerous studies estimating Salmonella prevalence and 
antimicrobial resistance in conventional and organic broiler hens and carcasses 
(20,21,61,62). Meanwhile, the number of studies comparing Salmonella in organic 
and conventional laying hen eggs and farming systems is relatively low and these 
studies have been reviewed predominantly performed in Europe (21). The objective 
of this study was to contribute to the body of knowledge surrounding Salmonella 
contamination in organic and conventional laying hen farms. Specifically, the study 
aimed to survey the environments (bedding, dust baths, past grass), fecal samples, 
feed/water and eggs for Salmonella, identify prevalence of commonly associated egg 
serovars and determine their antimicrobial resistance patterns of isolates present on 
these systems. 
2.3 Materials and Methods  
2.3.1 Sample Collection and Processing 
A total of 433 samples from 9 farms (three conventional and six organic) were 
collected between April 2013 and January 2014. Farms sampled were selected based 
on convenience to the research team and with the agreement of farm managers. With 
the exception of one organic farm located in Pennsylvania, all farms sampled were 
located in Maryland.  The numbers and types of sample take can also be seen in Table 
1. A total of 181 and 252 samples were collected from conventional and organic 
laying hen farms,, respectively. Organic farms tested in this study raised chickens free 




analyzed in this study included feces, eggs, feed, water and environmental. 
Environmental samples obtained from conventional farms (n=38) were limited to 
litter and flies, as conventional poultry had no access to an outdoor area while organic 
farms (n=76) included soil from dust baths, pasture grass, bedding and flies. Feed 
samples consisted of trough feed and water from both conventional and organic 
farms, with 57 and 79 samples taken, respectively. Two conventional farms were 
high-rise cage hen facilities with a deep pit manure collection system; the other 
conventional farm was a non-cage facility with litter (shavings and manure) 
management. Fecal samples were collected around the entire conventional house 
(n=74) and throughout the pasture and hen houses from organic farms (n=69). Eggs 
were sampled from both conventional farms (n=12) and organic farms (n=28) prior to 
cleaning. All samples were aseptically collected and placed into Whirl-Park bags 
(Nasco, Fort Watkinson, WI) and were transported to the laboratory in an ice cold 
carrier.  
Fecal and feed samples were subjected to enrichment in Luria-Bertani (LB) 
broth (AMRESCO, Solon, OH) supplemented with 5% Sheep blood (Ward’s Science, 
West Henrietta, NY) and were incubated overnight at 37°C. A 10 µL aliquot was 
streaked on XLT-4 (Difco, Sparks. MD) Agar plate. An additional aliquot was 
selectively enriched in Tetrathionate broth with iodine for another 24 h at 37°C 
(HiMedia, Mumbai, India). The selectively enriched samples were also streaked out 
on XLT-4 Agar plates. Egg samples were processed following the method previously 
described (63). Briefly, eggs collected from each site were washed with 10 mL of 




1 minute. After the vigorous mixing, BPW was incubated for 18-24 hours at 37°C, 
and then samples were incubated in LB supplemented with 5% Sheep blood at a final 
ratio of 1:10 and enriched for another 24 h in Tetrathionate broth at 37°C. Grass 
samples were weighed and BPW was added to the samples at a 1:10 ratio for pre-
enrichment, and mixed vigorously for 1 minute. Samples were then enriched and 
processed as described above. Presumptive positive colonies were black on XLT-4 
agar; one to three presumptive colonies was picked and wocked stocked in LB broth 
with 20% glycerol and stored at -20°C until further use. For biochemical tests, 
presumptive positive Salmonella colonies were inoculated into Simmons citrate, 
lysine iron (LIA) and triple sugar iron (TSI) agar (Difco) slant tubes and inoculated 
for 24 h at 37°C. Results were read and interpreted in accordance with the FDA’s 
Bacteriological Analytical Manual (64). 
2.3.2 Salmonella Identification by PCR 
Biochemically identified presumptive positive Salmonella isolates were 
confirmed by a set of PCR assays modified from Hong et al., and O’Regan et al 
(65,66). Salmonella serovars Enteritidis, Typhimurium and Heidelberg were targeted 
specifically due to the high association of these serovars to egg and poultry products 
identified in foodborne illness outbreaks (51). Genomic DNA from isolates was 
extracted from overnight grown cultures using the DNeasy Blood & Tissue Kit 
(Qiagen, Hilden, Germany). Primers used for PCR assays were purchased from 
Eurofins Scientific and are listed in Table 2. An initial aceK (Isocitrate 
dehydrogenase kinase/phosphatase) gene-specific PCR was used to confirm the 




for O, H1-1, H1-2 and H2 were used to identify their serovars as S. Heidelberg, S. 
Typhimurium or S. Enteritidis. The scheme for serovar identification is mentioned in 
Table 3. PCR reaction were run with a final volume of 10 µL using 1.5 mM MgCl2, 
0.04 U Choice-Taq DNA polymerase (Denville Scientific), 0.4 µM primer and 0.1 
mM dNTPs (Invitrogen, Carlsbad, CA). Thermocycler conditions for all PCR 
reactions were  94°C for 5 minutes, followed by 30 cycles of denaturation (94°C for 1 
minute), annealing (55°C for 30 sec) and extension (72°C for 1 minute) and a final 
step at 72°C for 5 minutes before being held at 4°C. Positive control strains used in 
this study were Salmonella enterica serovar Typhimurium ATCC 19485, Salmonella. 
enterica serovar Enteritidis ATCC 13076,  and Salmonella. enterica serovar 
Heidelberg ATCC 8326 . Escherichia coli (EDL933) ATCC 700927 was used as a 
negative control. Resulting PCR product was separated on 1.5% agarose gel with 
ethidium bromide at 100V for 30 minutes and a 1 Kb plus DNA ladder (Invitrogen, 
Carlsbad, CA) was used as molecular mass standard. 
 
2.3.3 Salmonella Antimicrobial Resistance Phenotyping 
Resistance of Salmonella isolates to a selected panel of antimicrobials was 
tested using a standard agar dilution method by the Clinical Laboratory Standards 
Institute (CLSI) (66). Mueller-Hinton (MH) Agar (Himedia, Mumbai, India) plates 
supplemented with two-fold serially diluted antimicrobials were prepared by mixing 
molten agar to antimicrobial solutions according to manufacturer’s instructions. Prior 
to testing, isolates were grown overnight on MH agar plates at 37°C. Using a sterile 
loop, isolated colonies were picked and bacterial cells were suspended and adjusted to 




suspension was added to 0.9 mL of saline solution and mixed well. Then, 2 µL of 
each bacterial suspension (~105 CFU) was added to MH agar plate containing 
antibiotic and incubated overnight at 37°C. The MIC was recorded as the lowest 
concentration of the antimicrobial agent that completely inhibited visible growth of a 
bacterial isolate. Results were interpreted in accordance with CLSI (2012) 
breakpoints and can be found in Table 4 (66). Isolates with intermediate resistance 
were classified as susceptible, since these isolates are able to be clinically treated with 
a higher than normal dosage of the drug. 
 
2.3.4 Statistical Analysis 
Comparisons of prevalence in farm type, sample type, antimicrobial resistance 
profiles and identification of Salmonella serovars, were carried out using SAS version 
9.3 (SAS Institute, Inc., Cary, North Carolina). For analysis, the samples were either 
categorized as conventional and organic depending on the farming system they came 
from. The PROC FREQ statement was used to perform χ2 tests to compare 
proportions of positive and antimicrobial resistant phenotypes. Fisher’s exact test was 
also used to compare proportions of isolates coming from each sample type and their 
farm origin. 
2.4 Results 
2.4.1 Prevalence of Salmonella in Conventional and Organic Laying Hens Farms 
In this study, a total of 433 samples were obtained from feces, feed, water and 
environments of three conventional (n=181 samples) and six organic (n=252 samples) 




identified in samples collected from both of the farming systems and overall 
prevalence was 16.1% (70/433). The prevalence of Salmonella in conventional and 
organic farms was significantly different  (p = 0.008), with 10.5% (19/181) and 
20.2% (51/252) contamination rates, respectively (Table 5).  
Salmonella contamination rates by sample type were also compared in organic 
and conventional farms. The organic poultry feces showed a significantly greater 
prevalence relative to that of conventional farms. Fecal samples revealed Salmonella 
contamination in 27.5% (9/74) of organic farms and 12.1% (19/69) of conventional 
farms (p = 0.03), a 16.1% difference in point estimate (Table 5).  
Overall, egg contamination on organic farms was not statistically significantly 
different from those samples on conventional farms, though Salmonella was found in 
10.7% (3/28) of the organic egg samples taken, compared to 0% (0/12) in 
conventional eggs. Furthermore, no statistically significant difference was found in 
the rates of Salmonella contamination in feed or environmental samples collected 
from the two farming systems. Due to differences in available laying hen housing 
systems on conventional and organic farms, environmental samples collected from 
organic farms were more diverse. However, bedding and fly samples were available 
on both organic and conventional farms and thus could be compared; on bedding 
available from organic farms we identified Salmonella from 9.5% (2/19) of the 
samples 18.8% (3/16) from that of conventional farms, though this difference was not 
statistically significant (Data not shown). Fly samples were collected more often on 




fly samples were positive for Salmonella but 0% (0/3)  of the fly samples from 
organic farms was positive.  
Serovar prevalence was also studied against S. Enteritidis, S. Typhimurium 
and S. Heidelberg (Table 6). For each sample tested, one to three presumptive 
colonies were streaked and stored at -20˚C. During testing for antimicrobial 
susceptibility, only one stock isolate was used per sample.  Out of the recovered 70 
Salmonella isolates, 34 (48.8%) and 1 (1.2%) were identified as S. Typhimurium and 
S. Enteritidis, respectively. However, none of the Salmonella isolates was identified 
as S. Heidelberg. The other 35 (50%) presumptive Salmonella isolates were 
collectively defined as Salmonella enterica. Among the 19 isolates recovered from 
conventional farms, 12 (63.2%) were S. Typhimurium while the remaining 7 (36.8%) 
were S. enterica. No S. Enteritidis was identified from the conventional isolates. Of 
the 51 isolates recovered from organic farms, 22 (43.1%) were identified as S. 
Typhimurium, and 1 (1.96%) was identified as S. Enteritidis. The other 28 (54.9%) 
were S. enterica. All three egg-shell samples isolates recovered from the organic farm 
were identified as S. Typhimurium (Table 6). 
2.4.2 Antimicrobial resistance features of Salmonella isolates. 
Antimicrobial susceptibility testing was performed on all 70 isolates against a 
wide range of antibiotic classes. Isolates were classified as either susceptible, 
antimicrobial resistant (AMR) or multidrug resistant (MDR). Pansusceptible isolates 
displayed no growth when challenged by all antimicrobials in the study, antimicrobial 
resistant isolates were resistant to only one antimicrobial and multidrug resistant 




isolates by sample and farm type is shown in Table 7. From conventional farms, 
15.7% (3/19) of Salmonella isolates were pansusceptible, while 73.7% (14/19) 
displayed multidrug resistance and 10.5%  (2/19) were single antimicrobial resistant. 
Isolates from the organic farms (n=51), 33.3% were multidrug resistant, 19.6% were 
single antimicrobial resistant and 47.1% were susceptible (Table 7). Statistical 
significance was not calculated for these values due to limitations of the χ2 test.  
Salmonella resistance to individual antimicrobials by farm type is shown in Table 8 
and resistance patterns in Table 9. The percentage of isolates resistant to cefazolin 
was significantly higher (p = 0.001) on conventional farms (84.2%) than organic 
farms (39.2%) (Table 8).  Ampicillin resistance was significantly higher (p = 0.05) in 
conventional isolates (73.7%, 14/19) when compared to organic isolates (51.0%, 
26/51). From conventional farm isolates, 52.6% (10/19) showed an ampicillin-
cefazolin resistant phenotype, followed by ampicillin-cefazolin-chloramphenicol 
resistant and susceptible phenotypes, which was found in equal proportions (15.8%) 
(Table 9). The leading phenotype for organic isolates was susceptible (45.0% 23/51) 
followed by ampicillin-cefazolin resistance (29.4%, 15/51). Regardless of the source 
of isolation and farm types, no isolate was resistant to gentamicin, ciprofloxacin, or 
trimethoprim-sulfamethoxazole.  
A summary of Salmonella serovars resistance to antimicrobials can be found 
in table 10. The S. Enteritidis isolate was susceptible to all antibiotics tested and all 
Salmonella showed susceptibility to trimethoprim-sulfamethoxazole, gentamicin and 
ciprofloxcain. Ampicillin and cefazolin were the antibiotics with highest resistance 




to all antibiotics tested. Of the 18 ampicillin resistant S. Typhimurium isolates, 9 
(50%) were isolated from the conventional farm the other 9 (50%) were isolated from 
organic farms. In addition, 50% (17/34) of S. Typhimurium isolates were resistant to 
cefazolin and out of these cefazolin resistant S. Typhimruium isolates 9 (52.9%) of 
the isolates were from the conventional farm and 8 (47.1%) were from organic farms. 
Of the 7 other S. enterica recovered from conventional farms, 5 (71.4%) were 
resistant to ampicillin and all 7 (100%) were resistant to cefazolin as well. Of the 
other 28 S. enterica identified on organic farms, 14 (50%) were resistant to ampicillin 
and 11 (39.9%) were resistant to cefazolin. 
2.5 Discussion 
Here, we investigated the prevalence of Salmonella in conventional and 
organic laying hen farms and determined the antimicrobial resistance profiles of 
isolated strains. Our results showed that the overall rates of Salmonella contamination 
were significantly higher by about 10% on organic farms than they were on 
conventional farms and it was consistent to some degree for each sample type tested 
including fecal, egg, feed and environmental. Previous reports indicate Salmonella 
poultry infection may be related to the presence of other domesticated animals, 
infected farm workers, rodents, wild-birds and insects (18, 71, 72,78).  Given the 
free-range and open grass land access to organic pasture layers, biosecurity level on 
these farms may be relatively decreased compared to conventional farms, thus 
increasing the possibilities of contamination with Salmonella and other zoonotic 
pathogens. With increased exposure to outdoors, chickens in these organic farming 




other domesticated animals, all who may introduce Salmonella into the farm (12, 15, 
67,71). However, other reports on European farms indicated that contamination rates 
of Salmonella on conventional farms were slightly higher than organic farms which is 
opposite to our findings (20,21,67,68,69). This anomaly might be due in part to the 
difference in farming infrastructures and their biosecurity measures in US and 
Europe. Another study found that the effect of housing systems was dependent on the 
age of hens on the farm (72). Though age was not considered as a parameter in this 
study, in the future it will be important to see whether age has any significant effect 
on Salmonella contamination. As mentioned above, environmental samples on the 
organic farms were also found to have a higher contamination rate than conventional 
farms except samples from flies. The exposure to vectors for horizontal transfer has 
been noted to increase Salmonella serovar diversity in poultry (78). On organic farms 
sampled, none of the flies were contaminated with Salmonella, while we recovered 
Salmonella isolates from 13.6% of conventional flies tested, accounting for 50% of 
all positive environmental samples on the conventional farms. Due to the dense 
nature of housing on the conventional farms, flies represent an important vector for 
Salmonella contamination. However, our inability to detect Salmonella on fly 
samples from organic farms may be due to low sample availability (71,79).  
In this study, S. Typhimurium was recognized as the most prevalent serovar in 
both farming systems but it was 20% higher on conventional farms than organic 
farms.  Compared to S. Typhimurium, only one S. Enteritidis was identified and 
isolated from an organic farm. Previous studies have found S. Enteritidis as the 




niche when serovars Pullorum and Gallinarum were targeted for eradication (10,73). 
Other studies have reported a decrease in S. Enteritidis on conventional laying hen 
farms, while others reported a large prevalence of Enteritidis, followed by 
Typhimurium (18,22,74). This low S. Enteritidis isolation in our study may be a 
positive sign, as it follows the decreasing trend that has been started since the 1990’s 
(9). More recently in 2009 the Food and Drug Administration had released final 
regulations with the intent to implement preventative measures, specifically with S. 
Enteritidis in mind. There are currently no concerted efforts targeting other individual 
Salmonella serovars. Results from studies focused on the changes of Salmonella 
serovar prevalence have indicated similar efforts to remove S. Pullorum of S. 
Gallinarum have resulted in an ecological niche modeled to be filled by S. Enteritidis 
(9). It will be important to continue surveillance of predominant Salmonella serovars 
related to chickens and their environments in order to detect the possible sources of 
new poultry associated Salmonella serovars.    
Antimicrobial resistance was found in 84.2% and 52.9% of Salmonella 
isolates from conventional and organic farms, respectively. These results are in 
agreement with studies showing higher prevalence of antimicrobial resistant 
Salmonella on conventional poultry farms (17, 83, 84,85). Similar findings have been 
also identified in Campylobacter spp. isolated from the intestines of broilers and 
turkeys from conventional and organic farms (86).  The administration of 
antimicrobials in feed may provide selective pressure on bacterial resistance on 
conventional farm environments (15,24). A study by Sapkota et al., (115) showed that 




prevalence of antimicrobial resistant Salmonella were found.  Organic farms are not 
allowed to use antimicrobial agents to raise their poultry. However, our study showed 
significant number of organic isolates were also resistant to either single or multidrug 
resistance. Indeed, class I integrons have been found in antimicrobial resistant 
Salmonella isolates from pasture-flock hens and organic poultry carcasses, which 
may account for antimicrobial resistance seen on organic farms in this study (25).   
Isolates from conventional farms showed high resistance to ampicillin, with 
73.7% showing resistance. Organic farm resistance to ampicillin was significantly 
different, with only 51% resistant to ampicillin. Our results are similar to findings 
from Sapkota et al., (115), who found ampicillin resistance decreased after farms 
transitioned from conventional to organic farming practices. Alali et al., (17) reported 
similar high prevalence rate of ampicillin resistance on conventional and organic 
broiler farms. However, our results conflict with ampicillin resistance from chicken 
Salmonella isolates reported by NARMS, which showed 7.3% of isolates showed 
resistance. Further, the NARMS report shows an increasing resistance to ceftriaxone, 
from 0.5% in 1997 to 6.3% in 2011. In contrast, our rates of ceftriaxone resistance are 
lower than the 2011 rates, with 5.3% and 1.96% from conventional and organic 
farms, respectively. Rates of cefazolin resistance have been previously reported 
(117). The resistance to both cefazolin and ceftriaxone is troubling because these 
cephalosporins have been recommended to treat Salmonella human infection (118). 
In our study, no isolates were resistant to ciprofloxacin, gentamicin and trimethoprim-





  Without the use of antimicrobials on the organic farms, there seems to be a 
lack of direct selective pressure on the Salmonella isolates retrieved from these 
systems. However, naturally occurring compounds in these areas may be conferring 
the selective pressures. A number of antimicrobials are naturally produced by fungi 
and other bacteria, and these organisms may be present on the farms providing some 
pressure. Moreover, the wild-life, especially migratory birds, moving in and out of 
these environments may be coming from highly populated areas, bringing 
antimicrobial resistant Salmonella into these environments (128). The continued 
resistance seen in these Salmonella on organic farms may be indicative of certain 
increased fitness increases seen, possibly due to compensatory mutations, which has 
been shown in vitro. However, it is understood that generally the introduction of 
antimicrobial resistance comes at a decreased fitness cost and these compensatory 
mutations must be studied further (129). Moreover, environmental stressors, such as 
growth-compromising conditions, have been thought to help promote the 
development of antimicrobial resistance, though definitive links between 
environmental Salmonella and antimicrobial resistance have yet to be identified 
(130). 




Chapter 3: The Efficacy of Salmonella Specific Egg-Yolk 
Antibodies (IgY) in Decreasing Salmonella Adherence to 
Chicken Cells In Vitro 
 
3.1 Abstract 
Salmonella remains an important causative agent of foodborne illness in the 
United States. Considering the majority of foodborne illness salmonellosis cases 
come from poultry and poultry products, controlling this pathogen has become an 
increasingly important objective for the poultry industry. In particular, the organic 
poultry industries, which are unable to use antibiotics, require new alternatives to 
control the pathogen at the production level. A possible alternative to antibiotics is the 
use of passive immunization through the oral ingestion of antigen-specific antibodies. 
The objective of this study was to determine the efficacy of antigen-specific 
antibodies to decrease the adherence of Salmonella to different chicken cells in vitro. 
Salmonella serovars S. Enteritidis and S. Typhimurium were tested for their ability to 
adhere to the DF-1 chicken fibroblast cell line and the HD-11 chicken macrophage 
cell line. Overall, when pre-treated with the different antibodies, the DF-1 fibroblast 
poultry model showed a significant decrease (p < 0.05) in the number of S. Enteritidis 
and S. Typhimurium, of approximately 1.5 log, depending on concentration and 
antibody treatment used. However, in the HD-11 cell line, antibody pre-treatment in 
some cases showed a significant increase in Salmonella adherence, of up to 0.5 log 
CFU ml-1.  While a modest decrease in Salmonella adherence may reduce the level of 
Salmonella contamination, further understanding of antigen-specificity and poultry 






Salmonella is a Gram-negative enteric pathogen which is estimated to cause 
1.4 million domestically acquired foodborne illnesses annually (49). Infection with 
the pathogen causes the disease salmonellosis, which occurs 12-72 hours after 
infection and manifests itself through diarrhea, fever and abdominal pain that lasts for 
4-7 days. It is estimated that the economic burden of foodborne Salmonella infections 
ranges from $1.5 billion to $10.9 billion annually (3). In 1998-2008, out of 1,491 
reported Salmonella foodborne outbreaks, 403 were traceable to a single serotype and 
single food source; out of the 403 outbreaks, Salmonella enterica serovar Enteritidis 
accounted for 144 outbreaks of which 65% were attributed to eggs and 13% were 
attributed to chicken products (2). On the other hand, Salmonella enterica serovar 
Typhimurium caused 58 outbreaks between 1998 and 2008, and eggs and poultry 
were implicated in 7% and 26% of those cases, respectively (2). It is believed that 
reduction of Salmonella in the intestines of birds will reduce contamination of future 
food-products from these livestock (46) 
 Adhesins play an important role in the pathogenesis of many enteric 
pathogens including Salmonella (44, 90). The presence of these surface structures 
allow Salmonella serovars to adhere to a variety of surfaces; in S. Enteritidis 
infection, type 1 fimbriae is implicated in poultry oviduct adherence and flagella is 
associated with poultry gut explant adherence (40, 91-93). S.Typhimurium utilizes 
type 1 fimbriae to attach to HeLa cells, and a variety of other fimbriae for biofilm 
formation on chicken intestinal epithelium (42, 43).  Nevertheless, the role of 




tissues remains poorly understood, and hence requires further research. It is important 
to better understand adhesins necessary for Salmonella attachment, because this 
initial step is required for colonization and invasion (90, 94). One of possible strategy 
to block the initial adherence of Salmonella is proper vaccination. While successful 
vaccination resulting in protection against a pathogen depends on a number of factors, 
vaccination against antigens may prevent attachment of bacteria to the host cell and 
colonization of mucosal surfaces (95). Development of novel vaccine against these 
structures may be worthwhile to protect against Salmonella infection.  
 In contrast to active immunity provided by vaccination, passive protection 
through the oral ingestion of antibodies may be effective as a supplemental strategy in 
the protection of chicken from Salmonella. Hens are able to pass up to 100 mg of a 
single class of antibodies, known as immunoglobulin Y (IgY) from their serum 
specifically into the egg-yolk and after immunization against an antigen, 
approximately 2-10% of these IgY found in the egg-yolk will be antigen-specific (96, 
97). Oral administration of specific antibodies found in egg-yolk from vaccinated 
laying hens may be able to prevent colonization from enteric pathogens, though 
previous studies have shown mixed results (39, 46, 48, 98, 99). While IgY produced 
against Salmonella outer membrane protein antigens have shown decreased 
adherence of S. Enteritidis and S. Typhimurium to Caco-2 cells in vivo, performance 
with these antibodies showed no protective effect against cecal contamination (103). 
Another study utilizing ducklings showed feed supplementation with probiotics and 
anti-S. Enteritidis IgY showed a significant decrease in Salmonella cecal, ileal, liver 




vivo studies have been performed on chickens,  no studies have focused on the effects 
of anti-Salmonella IgY on Salmonella infection using in vitro chicken cell line 
models. The purpose of this study was to evaluate the efficacy of egg-yolk antibodies 
directed against different Salmonella antigens in preventing Salmonella adherence to 
different poultry cell lines: a DF-1 chicken fibroblast cell line and the HD-11 chicken 
macrophage cell line. Estimating the efficacy of the antibodies to decrease Salmonella 
adhesion with chicken cells in vitro may allow us to better design vaccines for 
effective passive immunization in vivo. 
3.3 Materials and Methods 
3.3.1 Bacterial Strains and Growth Conditions 
Two strains, Salmonella enterica serovar Typhimurium LT2 ATCC 19485 
(ST) and Salmonella enterica serovar Enteritidis ATCC 13076 (SE) were used in this 
study. These strains were kindly provided by Dr. Steven C. Ricke, University of 
Arkansas. The strains were cultivated and maintained regularly on Luria-Bertani agar 
(HiMedia, Mumbai, India) at 37°C overnight in aerobic conditions. 
3.3.2 Cell Lines and Culture Conditions 
The chicken macrophage-like cell line HD11 was kindly provided by Dr. Uma 
S. Babu, at the Immunobiology Branch, Food and Drug Administration (Laurel, MD).  
The chicken fibroblast cell line DF-1 used was kindly provided by Dr. John Song, 
University of Maryland. The cells were cultured in Dulbecco’s Modified Eagles 
Medium (DMEM) (Corning Cellgro, Manassas, VA), with 2 mM L-glutamine, 4.5 




bovine serum (Corning Cellgro, Manassas VA) and were maintained at 37°C with 5% 
CO2.  Prior to infection, either 2×105 or 2×106 DF-1 or HD-11 cells, respectively, 
were seeded into 24- well culture plates (Greiner Bio-One, Monroe, NC) and allowed 
to proliferate to confluence for 24 h at 37°C. Before infection, the seeded culture-
plates were washed with 1x phosphate buffered saline (PBS) and replaced with fresh, 
non-supplemented DMEM. 
3.3.3 Immunization and Isolation of Immunoglobulin Y (IgY) from Egg Yolk 
Powders 
We worked with the company ZymeFast Inc., in order to immunize and 
collect the eggs from hens vaccinated against four different antigens. Currently, the 
antigens used for vaccination are under patent review and must remain confidential 
until final approval.  After immunization, egg-yolks were collected, lyophilized and 
sent to the University of Maryland; the antibody powders were stored at 4°C until 
used. Antibodies will be referred to as IgY1, IgY2, IgY3 and IgY4 for the remainder 
of the manuscript. The IgY was obtained from the egg-yolk powders using the 
method described by Lee et al. (48), with little modifications. In brief, approximately 
10 g of egg yolk powder was added to 80 ml of cold acidified distilled water (pH 4.0, 
with 0.1 N HCl) and mixed gently. Then, 10 ml of cold acidified distilled water (pH 
2.0) was added and mixed thoroughly before adjusting the final pH of solution to 
5.0~5.2. This solution was incubated overnight at 4°C for at least 12 h. The solution 
was centrifuged at 3,500 x g at 4°C for 20 min in a Thermo Scientific Sorvall Legend 




NaOH and stored at -20°C until further use. IgY concentration was determined using 
Thermo Scientific Pierce BGG Protein Assay Kit (Rockford, IL). 
3.3.4 Specific Activity of IgY 
Specific activity of the IgY against S. Typhimurium and S. Enteritidis was 
carried out using an indirect enzyme-linked immunosorbent assay (ELISA) as 
described by Zhen et al. (127) and Biswas et al. (126).  Salmonella cells were 
collected from overnight grown LB agar plates and suspended in PBS followed by 
centrifugation at 8,000 x g for 5 min. The supernatant was discarded and the bacterial 
cell pellet was then inactivated in 20 ml of 10% formalin and incubated for 3 hours at 
37°C with agitation (100 rpm). The treated cells were washed with PBS to remove 
excess formalin. All of the following reagents were added at 100 µL/well. The 
bacterial suspension was spotted on LB agar and incubated overnight to confirm 
inactivation.  The inactivated bacterial suspensions were diluted to an OD600 of 0.4 
using a PerkinElmer Lambda Bio + spectrophotometer (Waltham, MA), added to 96-
well microtiter plates and incubated for 2 h at 37°C. The plates were washed 3-4 
times with 200 uL of PBS plus 0.05% Tween-20 (PBST), and blocked with 5% non-
fat dry milk in PBST for 2 h at 37°C. A washing step was performed again and IgY at 
a final concentration of 7.5 µg ml-1 was added and incubated for another 2 h at 37°C. 
The plate was further washed with PBST and 100 uL of a peroxidase-conjugated goat 
anti-chicken IgG (Rockland, Boyertown, PA) was added to the wells and the plate 
was incubated for 1 h at 37°C. The microtiter plate was washed again and 3, 3’, 5, 5’- 
Tetramethylbenzidine (AMRESCO, Solon, OH) was added to the plates and 




absorbance at 450 nm (A450) was recorded with a ThermoScientific MultiSkan 
(Waltham, MA) microplate reader. 
3.3.5 Adherence Assays 
The ability of the antibodies to block adherence of Salmonella was carried out 
using both DF-1 and HD-11 cells. Prior to infection, DF-1 and HD-11 cell 
monolayers were incubated with 1.5,3 or 6 mg ml-1 of IgY at 37°C for 1 hr in 
nonsupplemented DMEM. Controls were incubated with an equivalent volume of 
distilled water. Suspensions of S. Enteritidis and S.Typhimurium were adjusted to an 
OD600 of 0.1 corresponding to 108 CFU ml-1; both bacteria were infected with a final 
MOI of 100 for DF-1 fibroblasts and a MOI of 10 for HD-11 cells and allowed to 
infect for 1 h at 37°C. After 1 h of infection, monolayers were washed twice carefully 
with 1 x PBS to remove nonadherent bacteria. The cells were then lysed by 
incubating monolayers with 0.1% Triton X-100 in PBS for 15 minutes at 37°C. The 
bacterial suspension was serially diluted and 50 uL of appropriate dilutions were 
plated on LB agar to enumerate the number of adhered Salmonella cells  
To test the effect of antibodies after an initial infection of chicken cells with 
Salmonella, DF-1 monolayers in 24-well cell culture plates were infected Salmonella 
strains as previously described. After 1 h incubation at 37°C, 5% CO2, the IgY was 
added to the cell/bacteria mixture at the same concentrations and allowed to incubate 
for an additional 1 h at 37°C. Enumeration of adhered bacteria was performed as 
described above. Each experiment was carried out in triplicate and replicated a total 




3.3.6 Statistical Analysis 
All experiments were conducted with three replicates in triplicate. Data were 
analyzed using Statistical Analysis Software version 9.3 (SAS Institute, Inc., Cary, 
North Carolina). The mixed model and Bonferroni’s correction were used to evaluate 
the treatments as fixed effect and for multiple comparisons. Significant mean 
differences were considered at P < 0.05.  
3.4 Results 
3.4.1 IgY Antibody Reactivity 
The ability of the four egg-yolk antibodies to bind was tested against both S. 
Enteritidis and S.Typhimurium. All antibodies were significantly more reactive for 
both Salmonella serovars when compared to the negative control. Moreover, 
antibodies were significantly more reactive (p < 0.0001) with S. Enteritidis than S. 
Typhimurium, with an overall mean average difference of 0.07. IgY 2 had the 
significantly highest reactivity with S. Enteritidis (A450 1.02 ± 0.02), followed by IgY 
4, IgY1 then IgY 3 (Figure 1). The pattern of antibody reactivity for S. Typhimurium 
differed from the S. Enteritidis reactivity. For S. Typhimurium, IgY 2 (A450 of 0.91 ± 
0.07) and IgY1 (A450 of 0.84 ± 0.03) showed statistically similar reactivity and both 
differed significantly from IgY 4 and IgY 3 (Figure 1). IgY 2 had similar reactivity 
against both S. Enteritidis and S. Typhimurium, while IgY 1 was the only other 
antibody treatment that had a higher reactivity with S. Typhimurium when compared 





3.4.2 Adhesion Prevention Assay  
The protective ability of the egg-yolk antibodies was tested in two different 
chicken cell lines with both pathogens. For S. Enteritidis infection, the preincubation 
of the antibodies with the DF-1 cell monolayer significantly changed the number of 
adhered bacteria (p<0.05) and was dependent on the treatment used as well as the 
concentration applied (Fig 2A). When compared to the control treatment, of 0 mg ml-
1, there was a significant concentration dependent reduction of S. Entertidis seen for 
each IgY treatment. Even the smallest reduction seen in IgY 2 at 1.5 mg ml-1, was 
significant with an average reduction of 0.84 log CFU ml-1(Fig 2A). At the highest 
concentrations tested, IgY 4 and IgY 1 were the most effective against reducing S. 
Enteritidis adhesion, when compared with treatment with IgY 2 and IgY 3. At 6 mg 
ml-1, the most significant decrease was found with antibody IgY4 showed a 1.78 log 
reduction in the pathogen adherence with the DF-1 fibroblast cell line, while the same 
concentration of IgY1 reduced S. Enteritidis adherence by 1.67 log CFU ml-1 (Fig 
2A). In contrast, the highest log reduction of antibody IgY2 and IgY3 was 1.43 log 
and 1.36 log, respectively.  
For S. Typhimurium, preincubation of the antibodies also significantly 
decreased the adherence of the pathogen with the DF-1 cell monolayer when 
compared to the control. For S. Typhimurium infection, there was only one 
significant difference seen between the different antibodies at a concentration of 3 mg 
ml-1 (p <0.05) and each treatment showed a significant effect of concentration (p < 
0.0001). For example, when compared to the control, at 1.5 mg ml-1 IgY 2 showed an 




treatment showed significantly different (p <0. 0001) 1.61 log CFU ml-1 decrease in 
bacterial adhesion. A similar concentration dependent decrease in S. Typhimurium 
was seen in IgY 3, where 1.5 mg ml-1 showed a 1.14 log CFU ml-1 decrease compared 
6 mg ml-1, which showed a significantly different (p < 0. 0001) decrease of 1.77 log 
CFU ml-1 (Fig 2B).  
Effect of preincubation of the antibodies with the macrophage HD-11 cells on 
Salmonella adherence was more nuanced. In S. Enteritidis infection overall, there was 
a significant effect of the different IgY concentrations, however this effect depended 
on the IgY treatment applied (p < 0.0001). As compared to the control, antibodies 
IgY 1 and IgY 4 caused an average decrease of S. Enteritidis adherence to the 
macrophages when compared to IgY 2 and IgY 3. A concentration of 1.5 mg ml-1 of 
IgY 1 showed the highest average adherence decrease of 1.06 log CFU ml-1 while 6 
mg ml-1 of IgY 4 caused an average 0.89 log CFU ml-1 decrease (Fig 3A). Antibody 
IgY 2 showed an increase in the adherence of S. Enteritidis with HD-11 cells at the 3 
and 6 mg ml-1 of 0.40 and 0.52 log CFU ml-1 respectively, when compared to the 
control. Treatment with antibody IgY 3 at 1.5 mg ml-1 showed a significant decrease 
(0.84 log CFU ml-1) while higher concentrations showed no significant effect.  
Preincubation of the antibodies with the macrophages and subsequent 
infection with S. Typhimurium showed a similar pattern to S. Enteritidis. There was a 
significant effect of the concentration of IgY treatment, but this effect depended on 
the IgY treatment used ( p < 0.0001).  In S. Typhimurium infection, the 6 and 3 mg 
ml-1 of IgY 2 showed a significant increase in the number of adhered bacteria to the 




Antibody treatments IgY 1 and IgY 3 showed no significant impact on the number of 
adhered S. Typhimurium. Preincubation with antibody IgY 4 showed a significant, 
concentration dependent decrease in the number of adhered of S. Typhimurium with 
the HD-11 cells with the largest decrease of 0.8 log CFU ml-1 at 6 mg ml-1(Fig 3B).  
The ability of the antibodies to decrease the adherence of Salmonella in a pre-
existing infection was tested by incubating the monolayer after an initial infection 
period. For both S. Enteritidis and S. Typhimurium infection, there was no significant 
effect seen between each antibody treatment, however for there was a significant 
effect (p < 0.0001) of the concentration of antibody applied on the number of CFU 
ml-1 adhered to the cells (Fig 4). After initial S. Enteritidis infection, antibody 
treatments at 6 and 3 mg ml-1 were able to significantly decrease the adherence of the 
pathogen with the monolayer. The most marked decrease in adherence when 
compared to the control could be seen with IgY 4 at 6 mg ml-1, with an average 
decrease 1 log CFU ml-1. For S. Typhimurium infection, a significant concentration 
dependent decrease of adherence was seen in IgY 4, with an average decrease of 0.6 
log CFU ml-1. 
3.5 Discussion 
The ability of specific egg-yolk antibodies to prevent infection through enteric 
pathogens has been previously documented. Specifically, anti-Salmonella egg-yolk 
antibodies have been studied both in vitro and in vivo with varying success. As S. 
Enteritidis and S. Typhimurium possess diverse mechanisms to attach to different 
host tissues, a variety of reasons may account for the differences in success seen 




For adherence assays, both preinubcation and postincubation of the antibodies 
showed a decrease in the adherence of Salmonella to the DF-1 fibroblast cell line. 
Preincubation of the antibodies with the cells resulted in a larger decrease of adhered 
Salmonella than treatment after an established infection.  The ability of the antibodies 
to decrease the adherence of the Salmonella to the cells is in accordance with 
previous findings in both Caco-2 and HeLa cells (101-103).  IgY 4 showed the 
second highest reactivity to S. Enteritidis, while showing the highest average decrease 
in adherence when DF-1 cells were pretreated. In contrast, IgY 2 showed the highest 
reactivity to S. Typhimurium and the greatest average decrease in adherence to 
pretreated DF-1 cells. Previous studies have looked at the effects of antigen specific 
IgY designed against outer membrane proteins (OMP, porins), lipopolysaccharides 
(LPS) or flagella on the adherence of S. Typhimurium of S. Enteritidis and have 
showed anti-OMP IgY exhibit the highest level of protection (39, 126). The current 
study indicates that while antigen specific IgY may show reactivity with multiple 
serovars, pathogen specificity may be needed for vaccination when designing 
antibodies; it will be important to further elicudate the most important proteins 
necessary to block Salmonella adhesion. It is thought that the binding of antigen 
specific IgY will bind to some specific antigen on the bacterial surface and which 
may lead to the impairment of adhesions. Alternatively, the binding of the IgY to the 
surface of the bacteria may modify the attachment and lead to changes in Salmonella 
morphology (48). 
 In comparison, treatment of the cells with any IgY after the infection had 




concentration dependent effect was seen in S. Enteritidis infection. Views on 
Salmonella adhesion are contrasting and studies claim that either Salmonella the 
process is either slow or almost instantaneous (104 -106). Anti-Salmonella specific 
egg-yolk antibodies have been shown to have some inhibitory effects on the growth 
of S. Enteritidis and S. Typhimurium (48, 103). Low-density lipoproteins have been 
implicated as components present in the water-soluble fraction of the egg-yolk that 
may have this antibacterial activity, though activity has not been explored in 
Salmonella (103).  These results may suggest that although specific anti-Salmonella 
egg-yolk antibodies may help prevent the association of the pathogen to the intestinal 
tract, other components of the egg-yolk may provide a more transient protection 
against Salmonella gastrointestinal infection in poultry.  
Preincubation of the antibodies with the HD-11 macrophages showed a more 
varied response. Macrophages may be activated through the Fc receptor found on 
their surface; once the antibody binds to the surface of the pathogen, macrophage 
phagocytosis becomes more efficient (107). Further, the clearance of Salmonella 
depends on opsonization of the pathogen by specific antibodies (108). In both S. 
Enteritidis and S. Typhiurium infection, IgY 2 was able to increase the adherence of 
the pathogen with the macrophage, which may be indicative of this opsonization 
effect while antibodies 1, 3 and 4 generally decreased the adherence of Salmonella.  
Vaccination against only the O-antigen has been shown to be poorly immunogenic, 
however vaccination against an O-antigen covalently linked to carrier proteins have 
shown increased phagocytosis and bacterial clearance against S. Typhimurium and S. 




Salmonella vaccines have been developed for both killed and live attenuated strains, 
though live attenuated strains are thought to better stimulate a cell-mediated and 
humoral immune response (27, 111).  
Overall, anti-Salmonella specific egg-yolk antibodies caused a variety of 
responses in poultry cell culture models, suggesting the addition of the antibodies in 
poultry feed or water may cause a more complicated response in the poultry. The 
differences in the responses of the two cell-lines may be caused by differences in the 
Salmonella life cycle; while fibroblasts and macrophages may both play a role in 
persistent Salmonella infection, growth in these two cell lines is very different. Upon 
entrance to fibroblasts, Salmonella are thought to switch to a more nonproliferative 
and avirulent state while in macrophages, Salmonella promote replication and 
survival (112, 113). The results from the current study indicate that inclusion of the 
specific egg-yolk antibodies may be effective in providing protection against both S. 
Enteritidis and S. Typhimurium by decreasing adherence and increasing bacterial 
clearance. In order for adoption to occur at the farm level, the antibodies will need to 
block multiple serovars and strains from adhereing to gastrointestinal tissue. 
Moreover, further work will need to be done to determine the efficacy of the 
antibodies following in vivo gastrointestinal digestion. These antibodies provide a 






Chapter 4: Conclusion 
In summary, the results of the first baseline study sheds light on the 
prevalence and antimicrobial resistance patterns of three major Salmonella serovars 
associated with chickens and eggs products in conventional and organic laying hen 
environments in Maryland. These findings suggest that rates of prevalence and 
resistance of Salmonella on laying hen farms may be linked to poultry production 
practices. This study affirms the need for longitudinal studies to follow and confirm 
sources of Salmonella contamination on farms in order to identify where Salmonella 
are being introduced on the farm and how resistance is being developed. The results 
of the second study help uncover the efficacy of antigen-specific antibodies in 
blocking colonization of Salmonella in chicken. While showing promise, the study 
highlights the need for further studies understanding the host-pathogen interaction 
between Salmonella and the chicken. A more comprehensive understanding of 
Salmonella attachment will allow for a better antigen-specific IgY treatment and 
future studies should explore the possibility of combining other alternative therapies. 
Together, these studies contribute to the growing body of knowledge of Salmonella in 
laying hens and the feasibility of certain alternative therapies as organic production of 








Chapter 5:  List of Tables 
5.1 Table 1.Total number of samples collected by farm and sample type 
Subsection 1 
Sample Type Conventional Organic Total 
Fecal 74 69 143 
Environmentala 38 76 114 
Feedb 57 79 136 
Egg 12 28 40 
Total 181 252 433 
Organic environmental samples include free range pasture grass, soil, bedding & 
flies, while  conventional  environmental samples only included bedding & flies 



















Salmonella enterica.  
  















abe2 (C2) F: CGTCCTATAACCGAGCCAAC 
R: CTGCTTTATCCCTCTCACCG 
397 
prt (A/D1) F: ATGGGAGCGTTTGGGTTC 
R: CGCCTCTCCACTACCAACTTC 
624 









fliC (i) F: AACGAAATCAACAACAACCTGC 
R: TAGCCATCTTTACCAGTTCCC 
508 







fliC (r) F: CCTGCTATTACTGGTGATC 
R: GTTGAAGGGAAGCCAGCAG 
169 










fljB (II: e,n,x; e,n,z15) F: TAACTGGCGATACATTGACTG 
R: TAGCACCGAATGATACAGCC 
152 
a Primer set designed with genes or junctions between two genes used for designing 
primers 
b Primer set adapted from O’Regan et al., (66). 



























































MIC Interpretive Standard  
(µg/mL) 
















2/38  4/76 
Chloramphenicol Phenicol 8 16 32 
Ceftriaxone Cephems  1 2 4 
Ciprofloxacin Fluoroquinolone .06 .5-.12 1 




5.5 Table 5. Prevalence (no.) of Salmonella by farm and sample type 
      










































a n = No. of positive isolates and N = Total no. of isolates 
b p-values were calculated for sample types using Fisher’s exact test to compare 
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a AMR isolates were resistant to only 1 antimicrobial, MDR isolates were resistant to 2 or more antimicrobial classes. Susceptible 
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aAntimicrobials ciprofloxacin, gentamicin and trimethoprim/sulfamethoxazole are not listed since no isolates  
showed resistance to these antimicrobials 






































5.9 Table 9. Antimicrobial resistance patterns of Salmonella from organic and conventional laying hens 
      
 
     Antimicrobial 
     resistance patterna 
 
Prevalence of Salmonella isolates across farm type 
Conventional isolates  %  
(n/N)  
Organic isolates  %  
(n/N) 
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Cz  75 
(9/12) 




 39.3  
(11/28) 
Cl 8.3  
(1/12) 



















Chapter 6: List of Figures 
6.1 Figure 1. Reactivity of anti-Salmonella Antibodies Against S. Enteritidis and S. 
Typhimurium 
 
Indirect ELISA performed with four different IgY treatments against S. Enteritidis 
and S. Typhimurium. Data are represented as mean ± S.D. Lower case letters 
represent significant differences ( p < 0.05)  in antibody reactivity for different 
treatments across a single Salmonella serotype. Upper case letters represent 
significant differences ( p < 0.05) between reactivity of two Salmonella serovars for a 





6.2 Figure 2. DF-1 Pretreatment Adherence Prevention  
 
 
A: S. Enteritidis infected cells B: S.Typhimurium infected cells 
Bacterial adherence of S. Enteritidis or S. Typhimurium to DF-1 chicken fibroblasts 
before infection. Adhered bacteria are represented as mean log CFU ml-1 ± S.D. 
Lower case letters represent significant differences ( p < 0.05)  in numbers of adhered 
bacteria between different concentrations in a single treatment. Upper case letters 
represent significant differences ( p < 0.05) between number of adhered bacteria 






6.3 Figure 3. HD-11 Pretreatment Adhesion Prevention 
 
A: S. Enteritidis infected cells B: S.Typhimurium infected cells 
Bacterial adherence of S. Enteritidis or S. Typhimurium to HD-11 chicken 
macrophages before infection. Adhered bacteria are represented as mean log CFU ml-
1 ± S.D. Lower case letters represent significant differences (p < 0.05) in antibody 
reactivity for different treatments across a single Salmonella serotype. Upper case 
letters represent significant differences (p < 0.05) between reactivity of two 








6.4 Figure 4. DF-1 Posttreatment Adherence Prevention  
 
 
A: S. Enteritidis infected cells B: S.Typhimurium infected cells 
Bacterial adherence of S. Enteritidis or S. Typhimurium to DF-1 chicken fibroblasts 
after infection. Adhered bacteria are represented as mean log CFU ml-1 ± S.D. Lower 
case letters represent significant differences (p < 0.05) in antibody reactivity for 
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